AGT and hypertensive disorder: CIH has recently been shown to increase plasma angiotensin II levels in animals (Lu et al., 2017) and central interventions to inhibit angiotensin II type 1 receptor in CIH animals reduce PVN neuronal activation and decrease hypertension (Shell et al., 2016).